Table 1 A. niger strains used in this study
Name | Genotype | Notes | Background isolates | Reference |
|---|---|---|---|---|
MA169.4 | kusA::DR-amdS-DR, pyrG − | Progenitor strain for mutant construction | N402, AB4.1 | Carvalho et al. [22] |
MJK17.25 | kusA::DR-amdS-DR, pyrG + | pyrG positive control strain | N402, AB4.1, MA169.4 | Schäpe et al. [18] |
LB7.1 | kusA::DR-amdS-DR, pyrG + , ΔcsmB | – | N402, AB4.1, MA169.4 | This study |
LB8.18 | kusA::DR-amdS-DR, pyrG + , ΔcsmA | – | N402, AB4.1, MA169.4 | This study |
LB9.1 | kusA::DR-amdS-DR, pyrG + , ΔchsF | – | N402, AB4.1, MA169.4 | This study |
LB10.1 | kusA::DR-amdS-DR, pyrG + , ΔchsA | – | N402, AB4.1, MA169.4 | This study |
LB11.1 | kusA::DR-amdS-DR, pyrG + , ΔchsG | – | N402, AB4.1, MA169.4 | This study |
LB12.14 | kusA::DR-amdS-DR, pyrG + , ΔchsD | – | N402, AB4.1, MA169.4 | This study |
LB13.3 | kusA::DR-amdS-DR, pyrG + , ΔchsB | – | N402, AB4.1, MA169.4 | This study |
LB14.1 | kusA::DR-amdS-DR, pyrG + , ΔchsE | – | N402, AB4.1, MA169.4 | This study |
SD1.3 | kusA::DR-amdS-DR, pyrG + , ΔchsC | – | N402, AB4.1, MA169.4 | This study |
ME1.4 | kusA::DR-amdS-DR, pyrG + , ΔchsE, ΔchsD | – | N402, AB4.1, MA169.4, LB14.1 | This study |